About
Description
Services
Life Cycle Assessment (LCA)
Analyze the lifecycles of products and services with regard to their environmental impacts.
Viral Vector Production
Produce viral vectors for gene therapy and vaccine development.
Data Visualization
Visualize data collected from clinical trials and/or clinical research.
Emerging Market Opportunities
Analyze risks and opportunities in new markets for patient access to new treatments.
Adverse Event Reporting
Monitor and report adverse events related to drug products in clinical trials.
Organization members
Amanda Lee
Communications Director
William Kim
Data Analyst
Laura Martinez
Clinical Trials Coordinator
Michael Brown
Executive Director
Robert Garcia
Fundraising Director
Emily Davis
Research Scientist
Case Studies
Health Technology Assessment for Mucopolysaccharidosis (MPS)
This project involves conducting a Health Technology Assessment (HTA) for new treatments targeting Mucopolysaccharidosis, a group of rare metabolic disorders.
Clinical Trial Design for Fibrodysplasia Ossificans Progressiva (FOP)
This project focuses on designing clinical trials for Fibrodysplasia Ossificans Progressiva, a rare and debilitating condition that causes soft tissues to turn into bone.
Biomarker Development for Gaucher Disease
This project aims to develop novel biomarkers for Gaucher Disease to improve diagnosis and monitoring.
Gene Therapy for Alkaptonuria
This project aims to develop gene therapy treatments for Alkaptonuria through collaboration between researchers and patient advocacy groups.